Anúncio
Anúncio
MAZE
Maze Therapeutics, Inc. Common Stock
40.31
USDPatrocinado
+1.36
+3.49%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
40.30
-0.02
-0.04%
Relatórios de Lucros MAZE
Rácio de surpresa positiva
MAZE separação 2 de 4 últimas estimativas.
50%
Próximo Relatório
Data do Próximo Relatório
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/--
Mudanças implicadas de Q-- -1 (Revenue/ EPS)
--
/--
Maze Therapeutics, Inc. Common Stock earnings per share and revenue
On 06 de nov. de 2025, MAZE reported earnings of -0.66 USD per share (EPS) for Q3 25, beating the estimate of -0.72 USD, resulting in a 8.68% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.48% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Maze Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Maze Therapeutics, Inc. Common Stock reported EPS of -$0.66, beating estimates by 8.68%, and revenue of $0.00, 0% as expectations.
How did the market react to Maze Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -3.48%, changed from $29.63 before the earnings release to $28.60 the day after.
When is Maze Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Maze Therapeutics, Inc. Common Stock's next earnings report?
Based on --
analistas, Maze Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio